Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder

NCT01010204 is registered in ClinicalTrials.gov with K.N. Roy Chengappa as lead sponsor.

NCT NCT01010204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01010204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Lead sponsor
K.N. Roy Chengappa
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
March 31, 2013
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, smoking cessation